As the tainted heparin issue continues to reverberate around the globe, lawsuits continue to mount as those harmed by contaminated heparin, or the families of those who have died, seek compensation in the face of a complex and convoluted environment. In a word, whom do you blame? The manufacturer, for sourcing the tainted heparin from China in the first place? Or the government, for not providing the US Food and Drug Administration (FDA) with the necessary tools to police imports? In Missouri, they're suing the manufacturer -- in this case, for allegedly waiting too long to initiate a recall...
Patients with recently-implanted heart stents, vascular stents or grafts are wondering if they are going to be affected by the tainted heparin scare, after the US Food and Drug Administration last week alerted medical device manufacturers that they should review their sources of heparin. Some medical devices, including devices used in pulmonary bypass and in-vitro diagnostic procedures, are coated with heparin...
Deaths linked to contaminated heparin have soared in recent months, with the death toll now standing at 62, up from 19. While no deaths have been reported since Baxter International, the giant pharmaceutical company and one of the world's leading suppliers of heparin recalled virtually all of its heparin product, the concern over heparin and suspected problems with the supply chain from China, remains...
